从正邪转化探讨肿瘤病机与治疗*

doi:10.3969/j.issn.1006-2157.2021.02.015

北京中医药大学学报 ›› 2021, Vol. 44 ›› Issue (2): 183-187.doi: 10.3969/j.issn.1006-2157.2021.02.015

从正邪转化探讨肿瘤病机与治疗^*

刘燕¹, 吴耀松¹, 刘俊¹, 蒋时红², 杨铁柱³, 任闪闪¹, 陈玉龙^1#

1 河南中医药大学中医药科学院河南省中医方证信号传导重点实验室河南 450046;
2 河南中医药大学研究生院;
3 河南省洛阳正骨医院重症医学科

收稿日期:2020-08-12 出版日期:2021-02-28 发布日期:2021-02-21
通讯作者: #陈玉龙,男,博士,教授,博士生导师,主要研究方向:中医肿瘤方证相关研究,E-mail:cyl72621@163.com
作者简介:刘燕,女,博士,实验师
基金资助:
*国家自然科学基金项目(No.81373535),河南省科技厅河南省重点研发与推广专项(科技攻关)项目(No.202102310493),河南省高校重点科研项目(No.19A360014),河南中医药大学博士科研基金项目(No.BSJJ2018-03)

Pathogenesis and treatment of tumors from the perspective of “transformation between healthy qi and pathogenic qi”^*

Liu Yan¹, Wu Yaosong¹, Liu Jun¹, Jiang Shihong², Yang Tiezhu³, Ren Shanshan¹, Chen Yulong^1#

1 Academy of Chinese Medical Sciences, Henan Provincial Key Laboratory of TCM Pattern and Prescription and Signal Transduction, Henan University of Chinese Medicine, Henan 450046;
2 Graduate School, Henan University of Chinese Medicine, Henan 450046;
3 Intensive Care Unit, Luoyang Orthopedic-Traumatological Hospital of Henan Province, Henan 450000

Received:2020-08-12 Online:2021-02-28 Published:2021-02-21
Contact: Prof. Chen Yulong, Ph. D., Doctoral Supervisor. Henan University of Chinese Medicine, No. 156 Jinshui Dong Road, Zhengdong New District, Zhengzhou 450046. E-mail: cyl72621@163.com
Supported by:
National Natural Science Foundation of China (No. 81373535); Key R & D and Promotion Projects in Henan Province (No. 202102310493)

摘要/Abstract

摘要： 通过阅读文献,对正邪相互转化的关系进行探讨,并在古今文献报道基础上指出肿瘤发生的关键因素——“恶气”是由正气失和化邪,邪气伏而化恶产生的。恶气弥散、熏蒸、充斥于机体组织内部,为肿瘤的形成提供了温床,与现代医学肿瘤微环境的概念有着异曲同工之妙。治疗当和其不和、疏利气机,使邪气复正、恶气消散。基于正邪转化角度阐释恶气产生机制,可更好地解释肿瘤的中医病因病机,指导临床治疗。将恶气理论与肿瘤微环境相接轨,可从细胞和分子水平上揭示恶气的内涵,为中医理论现代化研究提供思路和借鉴。

关键词: 正邪转化, 恶气, 纠偏复正, 肿瘤微环境

Abstract: Based on an analysis of “transformation between healthy qi and pathogenic qi” discussed in literatures, this paper points out that “e qi” (evil qi) seems to be the key factor of tumor occurrence. “E qi” is transformed from “pathogenic qi” lurked within the body, which is transformed from disharmonious healthy qi. “E qi” diffuses, fumigates, and fills the body, providing a ‘hotbed’ for tumor formation, which is similar to the concept of “tumor microenvironment” in modern medicine. In treatment of tumors, harmonize the discordant and promote qi movement, thus turning the pathogenic qi back to healthy qi to dissipate the ‘e qi’. Through interpreting the mechanism of ‘e qi’ based on the transformation of healthy qi and pathogenic qi, we can better explain the etiology and pathogenesis of tumors in TCM and guide clinical treatment. By correlating the theory of ‘e qi’ with the tumor microenvironment, we hope to reveal the connotation of ‘e qi’ in the cellular and molecular level, and provide references for the modernization of TCM theories.

Key words: transformation between healthy qi and pathogenic qi, e qi (evil qi), guiding pathogenic qi transforming to vital qi, tumor microenvironment

中图分类号:

R273

刘燕, 吴耀松, 刘俊, 蒋时红, 杨铁柱, 任闪闪, 陈玉龙. 从正邪转化探讨肿瘤病机与治疗^*[J]. 北京中医药大学学报, 2021, 44(2): 183-187.

Liu Yan, Wu Yaosong, Liu Jun, Jiang Shihong, Yang Tiezhu, Ren Shanshan, Chen Yulong. Pathogenesis and treatment of tumors from the perspective of “transformation between healthy qi and pathogenic qi”^*[J]. JOURNAL OF BEIJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE, 2021, 44(2): 183-187.

参考文献

[1] 王圆圆,陈柯羽,张青.基于“正邪学说”的肿瘤标本理论及临床应用[J].中医杂志,2013,54(21):1808-1811.
Wang YY, Chen KY, Zhang Q. Tumor specimen theory based on “theory of vital qi and pathogenic qi” and its clinical application[J]. Journal of Traditional Chinese Medicine, 2013,54(21):1808-1811.
[2] 刘清华,王璐璐.基于中医正邪学说关系浅析肿瘤免疫治疗的理论探讨[J].中医肿瘤学杂志,2019,1(1):8-11.
Liu QH, Wang LL. A theoretical discussion on tumor immunotherapy based on the relationship between vital qi and pathogenic qi[J]. Journal of Oncology in Chinese Medicine, 20191,1(1):8-11.
[3] 石翎笙,贺娟.《黄帝内经》“正气”概念内涵辨析[J].北京中医药大学学报,2020,43(6):469-474.
Shi LS, He J. Analysis of the concept of “Zhengqi” in Huangdi Neijing[J]. Journal of Beijing University of Traditional Chinese Medicine, 2020,43(6):469-474.
[4] 烟建华,张俐敏.《黄帝内经》“邪”概念内涵的学术解读[J].中华中医药杂志,2007,22(8):507-510.
Yan JH, Zhang LM. Academic connotation of “pathogenic factors” in Huangdi Neijing[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2007,22(8):507-510.
[5] 梁艳,陈子杰,王慧如,等.论《黄帝内经》治疗和养生中的正邪观[J].吉林中医药,2017,37(11):1089-1091.
Liang Y, Chen ZJ, Wang HR, et al. Health qi and pathogenic qi in the treatment and health preservation of Internal Classic[J]. Jilin Journal of Chinese Medicine, 2017,37(11):1089-1091.
[6] 陈钢.正邪关系补论[J].成都中医药大学学报,2005,28(1):1-3.
Chen G. Supplementary discussion on the relationship between vital qi and pathogenic qi[J]. Journal of Chengdu University of TCM, 2005,28(1):1-3.
[7] 刘俊杰,肖长江,李姿蓉,等.运用辩证法解析争议中的“和法”[J].北京中医药大学学报,2016,39(6):449-451.
Liu JJ, Xiao CJ, Li ZR, et al. Using dialectics to discuss the controversial “harmonizing therapy”[J]. Journal of Beijing University of Traditional Chinese Medicine, 2016,39(6):449-451.
[8] 莫秀云,何旭敏,詹乐昌.浅谈“以毒攻毒”蕴含的中医邪正统一关系[J].中医研究,2004,17(2):6-7.
Mo XY, He XM, Zhan LC. Discussion on the unified relationship between vital qi and pathogenic qi of traditional Chinese medicine in “combatting poison with poison”[J]. Traditional Chinese Medicinal Research, 2004,17(2):6-7.
[9] 李晨旭,孟丹华,陈玉龙.陈玉龙谈恶气与肿瘤[J].中医药导报,2019,25(20):19-21,28.
Li CX, Meng DH, Chen YL. CHEN Yu-long Talks about Un-Vital qi and tumor[J]. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 2019,25(20):19-21,28.
[10] 陈玉龙,司富春,王庆其.恶气与肿瘤病机关系探讨[J].河南中医学院学报,2004,19(6):9-11.
Chen YL, Si FC, Wang QQ. Pathogenic factors and pathogenesis of tumor[J]. Journal of Henan University of Chinese Medicine, 2004,19(6):9-11.
[11] 王书杰,张永琴,韦艾凌.浅论痰瘀在原发性肝癌发生、发展及转移中的作用[J].中国中医基础医学杂志,2012,18(9):957-958,961.
Wang SJ, Zhang YQ, Wei AL. Discussion on the role of phlegm and blood stasis in primary hepatocellular carcinoma occurrence, development and metastasis[J]. Journal of Basic Chinese Medicine, 2012,18(9):957-958,961.
[12] 邹子骅,李峻岭.肿瘤微环境的理论及治疗进展[J].癌症进展,2019,17(23):2737-2740,2780.
Zou ZH, Li JL. Theories and treatment progress of tumor microenvironment[J]. Oncology Progress,2019,17(23):2737-2740,2780.
[13] Kim K, Sohn YJ, Lee R, et al. Cancer-associated fibroblasts differentiated by exosomes isolated from cancer cells promote cancer cell invasion[J/OL]. Int J Mol Sci, 2020(21):8153 [2020-08-07]. https://doi.org/10.3390/ijms21218153.
[14] 张超,王晓林,李晨辉,等.肿瘤与免疫细胞通过外泌体相互作用的研究进展[J].肿瘤学杂志,2020,26(6):469-474.
Zhang C, Wang XL, Li CH, et al. Research progress on the interaction between tumor and immune cells through exosomes[J]. Journal of Chinese Oncology, 2020,26(6):469-474.
[15] 顾军花,刘嘉湘.刘嘉湘教授“扶正治癌”理论核心及运用方法[J].中国中西医结合杂志,2017,37(4):495-499.
Gu JH, Liu JX. Core theory and application of Professor Liu Jiaxiang's theory on “strengthening vital qi to treat cancer”[J]. Chinese Journal of Integrated Traditional and Western Medicine, 2017,37(4):495-499.
[16] 李黎,周雍明,朴炳奎.朴炳奎治疗恶性肿瘤“和其不和”学术思想探究[J].中国中医药图书情报杂志,2018,42(3):67-69.
Li L, Zhou YM, Piao BK. Research on Piao Bing-kui's academic thoughts of malignant tumor treatment by “regulating the imbalance of the body”[J]. Chinese Journal of Library and Information Science for Traditional Chinese Medicine, 2018,42(3):67-69.
[17] 李惠惠,李全富.扶正解毒方对小鼠前胃癌诱导肿瘤相关巨噬细胞的影响[J].吉林中医药,2016,36(9):922-925.
Li HH, Li QF. Centralizer detoxification treatment of mice induced by gastric cancer before cancer research[J]. Jilin Journal of Chinese Medicine, 2016,36(9):922-925.
[18] 黎金华,田菲,邱崇笙,等.扶正散结方调控Lewis肺癌小鼠TAMs免疫重塑作用的相关研究[J].中国中药杂志,2015,40(6):1161-1165.
Li JH, Tian F, Qiu CS, et al. Relevant studies on effect of Fuzheng Sanjie recipe in regulating immune microenvironment remodeling of TAMs in lewis lung cancer mice[J]. China Journal of Chinese Materia Medica, 2015,40(6):1161-1165.
[19] 苏乐. 健脾化瘀方通过miRNA-570调控B7-H1/PD-1通路防治肝癌术后复发的体内机制[D].广州:广州中医药大学,2017.
Su L. Preventive and therapeutic effect of Jianpi Huayu decoction on postoperative recurrence of hepatocellular carcinoma by regulating B7-H1/PD-1 pathway through miRNA-570[D]. Guangzhou: Guangzhou University of Chinese Medicine,2017.

从正邪转化探讨肿瘤病机与治疗^*

Pathogenesis and treatment of tumors from the perspective of “transformation between healthy qi and pathogenic qi”^*

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	段海瑞, 刘培民. 上病下取法论治食管癌^*[J]. 北京中医药大学学报, 2021, 44(2): 188-192.
[2]	林小力, 谭炜焓, 朱风旖, 梁丹, 严然, 由凤鸣. 基于“左血右气”论左右半结肠癌变病机偏侧性^*[J]. 北京中医药大学学报, 2020, 43(5): 432-435.
[3]	秦媛媛,徐硕,向春婕,吴娟,王瑞平,吴震峰,詹瑧,张军峰. 胃癌气阴两虚证患者舌苔菌群与血清炎症代谢的相关性分析[J]. 北京中医药大学学报, 2020, 43(4): 334-342.
[4]	陈慧芳, 刘小丽, 谢伟, 刘君, 薛晓鸥. Ⅰ型和Ⅱ型子宫内膜癌患者中医证候差异性初探^*[J]. 北京中医药大学学报, 2020, 43(3): 259-264.
[5]	何伟. 从“风毒入络”论中晚期肺癌远端转移病机^*[J]. 北京中医药大学学报, 2018, 41(7): 542-546.
[6]	陈恂，燕晓茹，张培彤. 原发性支气管肺癌中医实证证候特点的研究^*[J]. 北京中医药大学学报, 2017, 40(11): 960-963.
[7]	周玉¹,关青青¹,刘守尧²,韩静¹,王芷乔³,吕萌⁴,曹丽双⁵,夏仲元^2#. 甲状腺癌术后中医证候聚类分析^*[J]. 北京中医药大学学报, 2017, 40(9): 783-789.
[8]	王婧, 郭珊珊, 侯丽, 陈信义, 田劭丹. 新加良附颗粒配合化疗治疗进展期胃癌临床研究^*[J]. 北京中医药大学学报, 2017, 40(7): 593-598.
[9]	王芷乔,周玉,关青青,夏仲元. 应用德尔菲法确立甲状腺癌中医证候的调查研究[J]. 北京中医药大学学报, 2016, 39(11): 955-960.
[10]	王珺,田劭丹,陈信义,周郁鸿. 孔圣枕中丹配方颗粒治疗心肾阴虚证肿瘤相关失眠疗效观察^*[J]. 北京中医药大学学报, 2016, 39(8): 696-700.
[11]	黄智莉,于天启,陈亚勇,郭珊珊. 补肾强骨方治疗多发性骨髓瘤临床观察^*[J]. 北京中医药大学学报, 2016, 39(6): 520-523.
[12]	冯枫,冯淬灵,张力. 原发性支气管肺癌中医证候与支气管镜下表现关系的初步探究^*[J]. 北京中医药大学学报, 2016, 39(5): 417-423.
[13]	周小军,张丽娟,陈江华,汪芸. Springbio蛋白芯片技术研究气虚质及鼻咽癌气虚癌变差异蛋白表达[J]. 北京中医药大学学报, 2015, 38(10): 709-715.
[14]	许仲宁，杨宇飞，何斌，丁宁. 晚期结直肠癌中医治疗优势病例特点探讨分析^*[J]. 北京中医药大学学报, 2015, 38(4): 277-279.
[15]	沈政洁, 程海波, 沈卫星, 吴勉华. 肿瘤炎性微环境与“癌毒”病机相关性探讨[J]. 北京中医药大学学报, 2015, 38(1): 14-17.

从正邪转化探讨肿瘤病机与治疗*

Pathogenesis and treatment of tumors from the perspective of “transformation between healthy qi and pathogenic qi”*

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

从正邪转化探讨肿瘤病机与治疗^*

Pathogenesis and treatment of tumors from the perspective of “transformation between healthy qi and pathogenic qi”^*